Pharmacotherapy News Network
PNN, or Pharmacotherapy News Network, is a multimedia organization dedicated to reporting news and publishing content related to the effective use of medications in healthcare. The network places significant focus on prominent medical journals and leading publications in various fields, including internal medicine, cardiology, infectious diseases, psychiatry, neurology, rheumatology, pharmacotherapy, pharmacy practice, pediatrics, and geriatrics. L. Michael Posey, BSPharm, MA, serves as the editor and publisher of PNN. With 40 years of experience in pharmacy and biomedical journalism, he has held editorial positions at eight different publications, including the Journal of the American Pharmacists Association, Pharmacy Today, APhA DrugInfoLine, The Consultant Pharmacist, Journal of Managed Care Pharmacy, Clinical Pharmacy, American Journal of Hospital Pharmacy, and Clinical Laboratory Science. Additionally, Posey has edited the Pharmacotherapy textbook and authored the book "Pharmacy: An Introduction to the Profession" along with "APhA’s Complete Review for the Pharmacy Technician." He has collaborated with various health-system pharmacist societies in Illinois, Virginia, Louisiana, Georgia, and Mississippi, as well as the Phi Delta Chi Pharmacy Fraternity.
Outlet metrics
Global
N/A
Country
N/A
Category
N/A
Articles
-
Dec 28, 2023 |
pharmaconews.net | Michael Posey
In the annual update of American Diabetes Association standards for diabetes care, the language used for obesity and weight management for the prevention and treatment of type 2 diabetes is now person centered and expanded to reflect its importance and support in the clinical literature. The Obesity Society endorses the revised section.
-
Dec 28, 2023 |
pharmaconews.net | Michael Posey
In its annual update of standards for diabetes care, the American Diabetes Association makes several key changes for the diverse population of older adults. For Medicare beneficiaries on any type of insulin, Recommendation 13.6 is now aligned with revised CMS rules allowing continuous glucose monitoring.
-
Dec 28, 2023 |
pharmaconews.net | Michael Posey
In the annual update of American Diabetes Association standards for diabetes care, the recommendations for pharmacotherapy now include a preference for insulin analogs or inhaled insulin over injectable human insulins (Recommendation 9.2) and early use of continuous glucose monitoring (CGM) and consideration for automated insulin delivery (AID) systems (Recommendation 9.4) for adults with type 1 diabetes.
-
Dec 27, 2023 |
pharmaconews.net | Michael Posey
Evidence indicates lower risks of oral and esophageal cancers when people reduce or cease alcohol use, according to a Special Report from a working group of the International Agency for Research on Cancer (IARC). The organization also identified gaps in research on alcohol-associated cancers, including oral, pharyngeal, laryngeal, esophageal (squamous-cell), liver (hepatocellular), colorectal, and breast cancers.
-
Dec 27, 2023 |
pharmaconews.net | Michael Posey
Infants at risk for respiratory syncytial virus (RSV)–associated lower respiratory tract infection responded positively to nirsevimab, a pragmatic study shows, with reduced hospitalizations for RSV-associated lower respiratory tract infection and fewer cases of very severe RSV-associated lower respiratory tract infection.
Contact details
No sites or socials found.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →